Drug
Glatiramer Acetate (Copaxone®)
Glatiramer Acetate (Copaxone®) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Ph phase_1
1
25%
Ph phase_3
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
completed125%
terminated125%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Efficacy and Safety of GTR in Comparison to Copaxone®
NCT01489254
unknownphase_1
An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
NCT02023424
unknownphase_4
Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
NCT00677664
terminated
An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
NCT00398528
Clinical Trials (4)
Showing 4 of 4 trials
NCT01489254Phase 3
Efficacy and Safety of GTR in Comparison to Copaxone®
NCT02023424Phase 1
An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
NCT00677664Phase 4
Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
NCT00398528
An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4